Tuesday 31 March 2026
07:00 [PST] 10:00 [EST] 15:00 [GMT]
Microsampling necessity, challenges and advancements in preclinical and clinical bioanalysis
Mircosampling in both preclinical and clinical drug development can enhance patient experience, support the 3R aims, broaden clinical trial diversity via decentralized clinical trials, and help assess bioanalytical drug effects more frequently. While the benefits of microsampling are very compelling, challenges of sample integrity, capillary vs venous blood samples, bridging studies, and regulatory acceptance have historically been a barrier to industry-wide adoption. In this webinar, we will review the trends, challenges, approaches and advancements of microsampling within Labcorp Bioanalytical Services, as well as predictions about the future of microsampling for bioanalysis.
What will you learn?
- Evolving trends supporting the need for microsampling in preclinical and clinical bioanalysis.
- Challenges of microsampling in preclinical/clinical bioanalysis across small and large molecules, as well as molecular modalities.
- Approaches and advancements in microsampling across a wide variety of modalities.
- Thoughts about the future of microsampling within bioanalysis.
